Joshua A. Roth - Group Health, Group Health Research Institute

基本信息

浏览量：45

职业迁徙

个人简介

I am a comparative effectiveness researcher with a background in health economics, epidemiology, and health services management.

研究兴趣

论文共 123 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review

Joshua A. Roth, Victoria W. Dayer, Mireia Jofre-Bonet,Alistair McGuire,Sean D. Sullivan

BioDrugsno. 3 (2025): 411-425

引用0浏览0WOS引用

Cost-efficiency and Expanded Access Modeling of Conversion to Biosimilar Bevacizumab in Metastatic Colorectal and Non-Squamous Non-Small Cell Lung Cancer in Medicare

Joshua A Roth, David Kratochvil, Stephanie Dorman,Mark Bernauer

Journal of medical economicsno. 1 (2025): 378-386

引用0浏览0WOS引用

The Price Effects of Biosimilars in the United States

Mireia Jofre-Bonet,Alistair McGuire, Victoria Dayer,Joshua A. Roth,Sean D. Sullivan

Value in Healthno. 5 (2025): 742-750

引用0浏览0WOS引用

The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study

Jingyan Yang,Basit I. Chaudhry,Andrew T. Yue,Joshua A. Roth,John M. Kelton,Ahmed Shelbaya,Lisa Tran,Meng Li

ADVANCES IN THERAPYno. 1 (2024): 349-363

引用0浏览0WOS引用

RWD162 the Potential of Real-World Data (RWD) for Informing FDA Biosimliar and Interchangeable Biosimlar Regulatory Decisions: Recommendations from a Multi-Stakeholder Expert Panel

C. Lockhart, J.L. Bosco, E. Li, Y.L. Ling, D. McCabe, C. McDermott,C. Walraven,J. Roth

Value in Healthno. 12 (2024): S605

引用0浏览0引用

A Descriptive Analysis of Real-World Oncology Biosimilar Use in Japan

Joshua A. Roth, Makan Rahshenas, Gregoire Nowacki, Nihar Masurkar,Ahmed Shelbaya,Kentaro Tajima,Stephanie Dorman,Chiho Ono

FUTURE ONCOLOGYno. 25 (2024): 1837-1850

引用1浏览0WOS引用

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients with High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

Wael Saber,Aasthaa Bansal, Lily Li,Bart L. Scott,Lindsey R. Sangaralingham,Viengneesee Thao,Joshua A. Roth, Winona Wright,Lotte M. G. Steuten,Joseph A. Pidala,Asmita Mishra,Richard T. Maziarz,Peter Westervelt,Joseph P. McGuirk,Corey Cutler,Ryotaro Nakamura,Scott D. Ramsey

JCO Oncology Practiceno. 4 (2024): 572-580

引用2浏览0WOS引用

Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review

Grace E Fox,Mark Bernauer,Jennifer M Stephens,Bianca Jackson,Joshua A Roth,Ahmed Shelbaya

ClinicoEconomics and outcomes research : CEOR (2024): 247-256

引用0浏览0WOS引用

Stakeholder Perspectives on the Sustainability of the United States Biosimilars Market

Sean D. Sullivan,Sophia Z. Humphreys, David Fox,Catherine M. Lockhart, Ashley Tait-Dinger, Juan Diego Betancourt, Kenneth M. Komorny,Ryan Haumschild, Barry Chester, Matthew Harman,Joshua A. Roth

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACYno. 10 (2024): 1065-1072

引用0浏览0WOS引用

EE138 Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: A Conceptual Framework

G. E. Fox,M. Bernauer,J. Stephens, B. Jackson,J. Roth,A. Shelbaya

Value in Health（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn